4.6 Review

Human cerebral organoids - a new tool for clinical neurology research

Journal

NATURE REVIEWS NEUROLOGY
Volume 18, Issue 11, Pages 661-680

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41582-022-00723-9

Keywords

-

Funding

  1. Special Research Programme (SFB) of the Austrian Science Fund (FWF) [F7804-B]
  2. FWF Stand Alone Grant [P 35680, P 35369]
  3. Austrian Federal Ministry of Education, Science and Research
  4. City of Vienna
  5. European Research Council (ERC) Advanced Grant under the European Union's Horizon 2020 programmes [695642, 874769]

Ask authors/readers for more resources

This article summarizes how human-derived organoid models can complement traditional methods to accelerate neurological research, discusses the different processes of neurodevelopment, and the application of organoid models in modeling neurological diseases.
The current understanding of neurological diseases is derived mostly from direct analysis of patients and from animal models of disease. However, most patient studies do not capture the earliest stages of disease development and offer limited opportunities for experimental intervention, so rarely yield complete mechanistic insights. The use of animal models relies on evolutionary conservation of pathways involved in disease and is limited by an inability to recreate human-specific processes. In vitro models that are derived from human pluripotent stem cells cultured in 3D have emerged as a new model system that could bridge the gap between patient studies and animal models. In this Review, we summarize how such organoid models can complement classical approaches to accelerate neurological research. We describe our current understanding of neurodevelopment and how this process differs between humans and other animals, making human-derived models of disease essential. We discuss different methodologies for producing organoids and how organoids can be and have been used to model neurological disorders, including microcephaly, Zika virus infection, Alzheimer disease and other neurodegenerative disorders, and neurodevelopmental diseases, such as Timothy syndrome, Angelman syndrome and tuberous sclerosis. We also discuss the current limitations of organoid models and outline how organoids can be used to revolutionize research into the human brain and neurological diseases. In this Review, Eichmuller and Knoblich discuss how human brain organoids can recapitulate the unique processes that occur in human brain development and how they can complement classical approaches to revolutionize research into neurological diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Amplification of human interneuron progenitors promotes brain tumors and neurological defects

Oliver L. Eichmueller, Nina S. Corsini, Abel Vertesy, Ilaria Morassut, Theresa Scholl, Victoria-Elisabeth Gruber, Angela M. Peer, Julia Chu, Maria Novatchkova, Johannes A. Hainfellner, Mercedes F. Paredes, Martha Feucht, Juergen A. Knoblich

Summary: The evolutionary development of the human brain involves the expansion of different brain regions. This study focuses on the specific developmental processes in humans that lead to malformations of cortical development, resulting in developmental delay and epilepsy in children. By creating a human cerebral organoid model for tuberous sclerosis complex (TSC), researchers identified a neural stem cell type called caudal late interneuron progenitor (CLIP) cells that overproliferate in TSC, leading to excessive interneurons, brain tumors, and cortical malformations. Inhibiting the epidermal growth factor receptor has potential therapeutic effects for TSC and related disorders. The discovery of CLIP cells highlights the vulnerability to disease in the extended generation of interneurons in the human brain, while also demonstrating the importance of analyzing malformations of cortical development in gaining insights into human-specific aspects of brain development.

SCIENCE (2022)

Article Biochemistry & Molecular Biology

Gruffi: an algorithm for computational removal of stressed cells from brain organoid transcriptomic datasets

Abel Vertesy, Oliver L. Eichmueller, Julia Naas, Maria Novatchkova, Christopher Esk, Meritxell Balmana, Sabrina Ladstaetter, Christoph Bock, Arndt von Haeseler, Juergen A. Knoblich

Summary: This study reveals that organoids experience cellular stress, but it is limited to specific subpopulations and does not affect neuronal specification or maturation. The researchers have developed an algorithm to identify and remove stressed cells, proving its usefulness in different organoid systems.

EMBO JOURNAL (2022)

Article Oncology

Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model

Laura Hartmann, Wolfram Osen, Oliver L. Eichmueller, Theresa Kordass, Jennifer Furkel, Elke Dickes, Carissa Reid, Jurgen Debus, Stephan Brons, Amir Abdollahi, Mahmoud Moustafa, Stefan Rieken, Stefan B. Eichmueller

Summary: Radiotherapy can activate tumor-specific immune responses in patients and combining carbon ion radiotherapy with immune checkpoint inhibition can reshape the immune cell composition in tumors and induce complete rejection of both irradiated and non-irradiated tumors.

CANCER LETTERS (2022)

No Data Available